Literature DB >> 23344895

Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease.

Ahmet Sert1, Ozgur Pirgon, Ebru Aypar, Hakan Yilmaz, Dursun Odabas.   

Abstract

No data are available on the relationship between subclinical hypothyroidism and risk factors for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease (NAFLD). This study aimed to determine whether an association exists between subclinical hypothyroidism and risk factors for the development of cardiovascular disease in obese adolescents with NAFLD. The study enrolled 111 obese adolescents and 42 lean subjects. The obese subjects were divided into two subgroups based on the presence or absence of fatty liver with high transaminases: a NAFLD group and a non-NAFLD group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone (TSH) level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Insulin resistance was calculated by the homeostasis model assessment (HOMA-IR). Left ventricular mass (LVM), LVM index measurements, carotid intima media thickness (IMT), and HOMA-IR values were higher in the NAFLD obese group with TSH levels higher than 4 mIU/l than in the NAFLD obese group with TSH levels lower than 4 mIU/l. Elevated TSH values in the NAFLD obese group were positively correlated with most of the metabolic and cardiovascular risk parameters such as total cholesterol (r = 0.606, p = 0.001), triglycerides (r = 0.476, p = 0.016), low-density lipoprotein cholesterol (r = 0.461, p = 0.004), insulin (r = 0.607, p = 0.001), HOMA-IR (r = 0.596, p = 0.002), carotid IMT (r = 0.894, p < 0.0001), and LVM (r = 0.563, p = 0.003). The findings demonstrated that the obese adolescents with NAFLD and subclinical hypothyroidism had a more adverse cardiovascular risk profile and a higher carotid IMT and LVM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344895     DOI: 10.1007/s00246-013-0638-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  38 in total

1.  Subclinical hypothyroidism and risk to carotid atherosclerosis.

Authors:  Velkoska Nakova Valentina; Bosevski Marijan; Dimitrovski Chedo; Krstevska Branka
Journal:  Arq Bras Endocrinol Metabol       Date:  2011-10

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study.

Authors:  Xiangrong Li; Shengxu Li; Eralp Ulusoy; Wei Chen; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

4.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study.

Authors:  J Willeit; S Kiechl; F Oberhollenzer; G Rungger; G Egger; E Bonora; M Mitterer; M Muggeo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

7.  During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat.

Authors:  Isabelle Aeberli; Andreas Jung; Stefanie B Murer; Johannes Wildhaber; Joanne Wildhaber-Brooks; Bruno H Knöpfli; Michael B Zimmermann
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

8.  Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients.

Authors:  Giovanni Targher; Martina Montagnana; Gianluca Salvagno; Paolo Moghetti; Giacomo Zoppini; Michele Muggeo; Giuseppe Lippi
Journal:  Clin Endocrinol (Oxf)       Date:  2007-10-17       Impact factor: 3.478

9.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.

Authors:  F Monzani; N Caraccio; M Kozàkowà; A Dardano; F Vittone; A Virdis; S Taddei; C Palombo; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

Review 10.  Nonalcoholic fatty liver disease in children.

Authors:  Melania Manco; Gianfranco Bottazzo; Rita DeVito; Matilde Marcellini; Geltrude Mingrone; Valerio Nobili
Journal:  J Am Coll Nutr       Date:  2008-12       Impact factor: 3.169

View more
  11 in total

1.  Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters.

Authors:  Tolga Unüvar; Ahmet Anık; Gönül Catlı; Ihsan Esen; Ayhan Abacı; Atilla Büyükgebiz; Ece Böber
Journal:  J Endocrinol Invest       Date:  2014-06-12       Impact factor: 4.256

2.  Isolated Hyperthyrotropinemia Adversely Influences Lipid Metabolism in Children and Adolescents with Obesity.

Authors:  Deniz Özalp Kızılay; Şebnem Uysal Ateş
Journal:  Turk Arch Pediatr       Date:  2022-05

3.  AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.

Authors:  Shudong Liu; Fei Jing; Chunxiao Yu; Ling Gao; Yejun Qin; Jiajun Zhao
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.

Authors:  Emel Torun; Ilker Tolga Özgen; Selim Gökçe; Sinem Aydın; Yaşar Cesur
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

5.  Thyroid function is associated with insulin resistance markers in healthy adolescents with risk factors to develop diabetes.

Authors:  José de Jesús Garduño-Garcia; Eneida Camarillo Romero; Ana Loe Ochoa; Socorro Romero-Figueroa; Gerardo Huitron Bravo; Roció Torres García; Patricia Montenegro-Morales; Hugo Mendieta-Zerón
Journal:  Diabetol Metab Syndr       Date:  2015-03-08       Impact factor: 3.320

6.  Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Authors:  Weiwei He; Xiaofei An; Ling Li; Xiaoqing Shao; Qian Li; Qiuming Yao; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-29       Impact factor: 5.555

7.  Bee Venom Suppresses the Differentiation of Preadipocytes and High Fat Diet-Induced Obesity by Inhibiting Adipogenesis.

Authors:  Se-Yun Cheon; Kyung-Sook Chung; Seong-Soo Roh; Yun-Yeop Cha; Hyo-Jin An
Journal:  Toxins (Basel)       Date:  2017-12-24       Impact factor: 4.546

8.  Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.

Authors:  Edip Unal; Alper Akın; Ruken Yıldırım; Vasfiye Demir; İsmail Yildiz; Yusuf Kenan Haspolat
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-12-23

9.  Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.

Authors:  Presley H Nichols; Yue Pan; Benjamin May; Martina Pavlicova; John C Rausch; Ali A Mencin; Vidhu V Thaker
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

10.  Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.

Authors:  Maurizio Nordio; Raffaella Pajalich
Journal:  J Thyroid Res       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.